Table 3.

Cancer Trial Enrollment and Mortality

Trial Enrollment	Overall Mortality Enrolled vs Not Enrolled HR* (95% CI)	Cancer Specific Mortality Enrolled vs Not Enrolled HR* (95% CI)
All Sites Included	0.74 (0.67–0.81)	0.74 (0.66–0.83)
Stratified By Disease Site
Lung	0.74 (0.62–0.88)	0.73 (0.60–0.87)
Colon	0.59 (0.45–0.78)	0.57 (0.42–0.77)
Breast	0.75 (0.59–0.94)	0.69 (0.52–0.90)
Melanoma	0.83 (0.61–1.12)	0.97 (0.69–1.37)
Esophagus/Stomach	0.86 (0.53–1.39)	0.77 (0.46–1.30)
Liver/Biliary/Pancreas	1.01 (0.82–1.26)	1.03 (0.82–1.28)

^*Adjusted for age, gender, marital status, race, payor, rurality of residence, year of diagnosis, organ site, tumor stage, tumor grade, care at a CoC hospital and treatment modalities received.